{"url_path":"/sec/labt/8-k/2026-06-17/item-3-03","section_key":"item-3-03","section_title":"Item 3.03 Material Modification to Rights of Security Holders.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/2079272/0001213900-26-069512-index.html","accession_number":"0001213900-26-069512","cik":"0002079272","ticker":"LABT","issuer_name":"Lakewood-Amedex Biotherapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2079272/0001213900-26-069512-index.html","primary_entity_key":"0002079272","primary_entity_name":"Lakewood-Amedex Biotherapeutics Inc."},"word_count":33,"has_tables":true,"body_markdown":"**Item 3.03. Material Modification to Rights of Security Holders.**\n\n \n\nTo the extent required by Item 3.03 of Form 8-K,\nthe information contained in Item 5.03 of this report is incorporated herein by reference."}